Miglustat

Miglustat is a pharmaceutical-grade active ingredient classified as Enzyme Inhibitor / Lysosomal Storage Disease. Mediocon Inc supplies high-purity Miglustat API conforming to IP / BP / EP / USP specifications, manufactured in our GMP-certified facility in Aurangabad, Maharashtra, India.

Key Features

• Glucosylceramide synthase inhibitor
• IP/BP/EP/USP compliant
• Full CoA and MSDS documentation
• GMP certified manufacturing

Applications

• Gaucher disease type 1 (substrate reduction therapy)
• Niemann-Pick disease type C
• Lysosomal storage disorder management

Why Choose Mediocon

• ISO 9001:2015 & GMP certified manufacturing
• Consistent batch-to-batch quality with full CoA
• Export-ready documentation: COO, MSDS, DMF
• Flexible MOQ for both R&D and commercial scale
• Dedicated QA support for regulatory filings